Clin2
NCT06815705Possibly a fitNot yet recruiting

Lymph system repair during head and neck cancer surgery

Head and Neck Squamous Cell CarcinomaLymphedema, SecondaryNeck Lymph DissectionVascularized Lymph Node Transplantation

Part of Blood & lymphatic, Cancer clinical trials.

This trial tests a new surgical method to rebuild the lymph system in your neck during surgery for head and neck cancer. It aims to reduce swelling and improve recovery after removing lymph nodes as part of cancer treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
23 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You are willing and able to have surgery to remove your head and neck cancer and to rebuild the tissue with a flap (moving tissue from another part of your body).
  • Your cancer has not spread to other organs (like lungs or liver) and has not spread to lymph nodes under your arm.
  • You have not had another type of cancer before.
  • You are generally healthy enough for surgery, with blood counts and organ function in a safe range (your doctor will check this).
  • You are not pregnant or breastfeeding, and if you could become pregnant or get someone pregnant, you agree to use effective birth control during the study and for a period after.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05854823Recruiting
Reduced radiation after surgery for advanced head and neck cancer

This trial looks at whether giving less (de-escalated) radiation after surgery is as effective and safer for people with locally advanced head and neck squamous cell carcinoma who had a strong response to treatment before surgery. If you had no remaining cancer or only very small amounts of cancer left in the surgical specimen, this approach may help reduce side effects while keeping control of the disease.

Zhuhai, Guangdong
NCT06323369Recruiting· Phase 2
Tislelizumab plus chemo before surgery vs surgery alone for head and neck cancer

This trial tests whether giving tislelizumab (an immunotherapy) with chemotherapy before surgery works better than surgery alone for people with head and neck cancer that has not spread to lymph nodes. It's for cancers that can be removed with surgery, and the goal is to see if the pre-surgery treatment improves outcomes.

Guangzhou, Yuexiu
NCT05889091Recruiting
Fat flap surgery to protect the neck after cancer treatment

This trial studies whether using a “fat flap” (a piece of your own fatty tissue, moved to the neck) during certain neck surgeries can reduce neck injury after head and neck cancer treatment. It is for people who need a salvage neck dissection because of persistent or returning cancer in the neck lymph nodes.

New York, New York
NCT06366945Not yet recruiting· Phase 2
Immunotherapy plus chemo before surgery for head and neck cancer

This trial tests a combination of an immunotherapy drug (tirelizumab) with two chemotherapy drugs before surgery for head and neck cancer that has spread to lymph nodes. The goal is to shrink the tumor and improve treatment outcomes.

NCT07369882Recruiting
Less extensive surgery after immunotherapy for advanced head and neck cancer

This trial compares a less extensive surgery to the standard surgery for patients with advanced head and neck cancer who have responded well to initial chemotherapy and immunotherapy. The goal is to see if a smaller operation can be just as effective while causing fewer side effects.

Guangzhou, Guangdong
NCT07694726Recruiting
Vein repair during neck surgery to prevent lymphedema

This study tests whether repairing veins during head and neck cancer surgery helps prevent lymphedema (painful swelling) after treatment. It may help patients who are having lymph node removal and will receive radiation afterward.

Pittsburgh, Pennsylvania

Hear when a new Head and Neck Squamous Cell Carcinoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.